Showing 821 - 840 results of 3,069 for search '"hypertension"', query time: 0.06s Refine Results
  1. 821
  2. 822
  3. 823
  4. 824
  5. 825

    Development of hypertensive complications in oocyte donation pregnancy: protocol for a systematic review and individual participant data meta-analysis (DONOR IPD) by Saskia le Cessie, Marie-Louise van der Hoorn, Jan van Lith, Eileen Lashley, Kim van Bentem

    Published 2022-07-01
    “…Compared with IVF and naturally conceived (NC) pregnancies, OD pregnancies have a higher risk for pregnancy complications as pregnancy-induced hypertension (PIH) and pre-eclampsia (PE). Various covariates among women pregnant by OD, however, also contribute to an increased risk for developing hypertensive complications. …”
    Get full text
    Article
  6. 826
  7. 827

    Effects of Fasudil on Patients with Pulmonary Hypertension Associated with Left Ventricular Heart Failure with Preserved Ejection Fraction: A Prospective Intervention Study by Xiang Zhang, Xueming Zhang, Saihua Wang, Jun Luo, Zhihong Zhao, Changzhu Zheng, Jieyan Shen

    Published 2018-01-01
    “…Background. Pulmonary hypertension due to left ventricular heart failure with preserved ejection fraction (PH-HFpEF) is an increasingly medical problem. …”
    Get full text
    Article
  8. 828

    Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application by Andrew E Moran, Sohel Reza Choudhury, Deliana Kostova, Muhammad Jami Husain, Mohammad Sabbir Haider, Mahfuzur Rahman Bhuiyan, Renesa Tarannum, Shamim Jubayer

    Published 2022-06-01
    “…Objective To estimate the costs of scaling up the HEARTS pilot project for hypertension management and risk-based cardiovascular disease (CVD) prevention at the full population level in the four subdistricts (upazilas) in Bangladesh.Settings Two intervention scenarios in subdistrict health complexes: hypertension management only, and risk-based integrated hypertension, diabetes, and cholesterol management.Design Data obtained during July–August 2020 from subdistrict health complexes on the cost of medications, diagnostic materials, staff salaries and other programme components.Methods Programme costs were assessed using the HEARTS costing tool, an Excel-based instrument to collect, track and evaluate the incremental annual costs of implementing the HEARTS programme from the health system perspective.Primary and secondary outcome measures Programme cost, provider time.Results The total annual cost for the hypertension control programme was estimated at US$3.2 million, equivalent to US$2.8 per capita or US$8.9 per eligible patient. …”
    Get full text
    Article
  9. 829
  10. 830

    Myocardium Assessment by Relaxation along Fictitious Field, Extracellular Volume, Feature Tracking, and Myocardial Strain in Hypertensive Patients with Left Ventricular Hypertrophy by Seyed Amir Mirmojarabian, Eveliina Lammentausta, Esa Liukkonen, Lauri Ahvenjärvi, Juhani Junttila, Miika T. Nieminen, Timo Liimatainen

    Published 2022-01-01
    “…Previous research has shown impaired global longitudinal strain (GLS) and slightly elevated extracellular volume fraction (ECV) in hypertensive patients with left ventricular hypertrophy (HTN LVH). …”
    Get full text
    Article
  11. 831
  12. 832
  13. 833
  14. 834
  15. 835
  16. 836
  17. 837
  18. 838
  19. 839
  20. 840